Iritero
Brand Name: Iritero
Generic Name: Irinotecan (as hydrochloride)
Active
Registration Number
DRP-8211
Dosage Form
Solution for Intravenous Infusion
Issuance Date
January 31, 2024
Expiry Date
May 31, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength100mg/ 5mL
PackagingIn a 5mL-capacity Glass Vial x 5mL with gray colored rubber stopper and rust colored flip-off seal (Box of 1's)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic (Cell Cycle-Specific Agent)
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Irinotecan (as hydrochloride)Active
Monograph: irinotecan (as hydrochloride)